azvudine: Clinical Trials

16 trials of azvudine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown, 5 completed, 2 recruiting. 6 Phase 3, 3 Phase 1, 3 Phase 2, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 36Unknown 3, Completed 2, Recruiting 1
Phase 13Completed 2, Recruiting 1
Phase 23Unknown 3
Not applicable1Unknown 1
Phase 41Unknown 1

Follow azvudine: new trials by email Literature Review of azvudine trials Research Report on azvudine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
AZVUDINE, TAF, IFNα-2a - Chronic Hepatitis B, Azvudine
Phase 3RecruitingZhigang Ren1202025-09-012025-12-29
A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects
Azvudine tablets - Renal Insufficiency
Phase 1RecruitingHenan Genuine Biotech Co., Ltd.402025-05-202025-06-03
The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19
Azvudine, Paxlovid - COVID-19, Azvudine
CompletedThe First Affiliated Hospital of Zhengzhou University328642023-12-052024-04-05
Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study
Azvudine - COVID-19
UnknownFifth Affiliated Hospital, Sun Yat-Sen University42012023-08-052023-09-21
Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
Azvudine, Placebo - COVID-19 Respiratory Infection
Phase 2 / Phase 3UnknownPeking Union Medical College Hospital10962023-04-192024-11-25
A Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly Subjects
Azvudine tablets - Healthy
Phase 1CompletedHenan Genuine Biotech Co., Ltd.242023-04-082025-11-17
A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection
Azvudine, Nirmatrelvir-Ritonavir - COVID-19
Phase 4UnknownShandong Provincial Hospital4102023-01-212023-02-27
Real-world Study Evaluating the Efficacy and Safety of Azvudine in Nursing Home Patients
Azvudine - COVID-19
UnknownShanghai Henlius Biotech4002023-01-152023-01-13
Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China
Azvudine, Placebo - COVID-19
Phase 2UnknownShanghai Henlius Biotech3002023-01-062023-01-31
Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19
Azvudine, Placebo - SARS-CoV-2 Infection
Phase 2 / Phase 3UnknownShanghai Henlius Biotech15502022-12-292023-01-09
An Observational, Ambispective Cohort Study of Azvudine in the Treatment of Patients With COVID-19 Pneumonia
Azvudine - COVID-19 Respiratory Infection
UnknownQianfoshan Hospital5002022-11-222023-10-03
The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial
Azvudine, Paxlovid group - SARS-CoV-2 Infection
Not applicableUnknownSoutheast University, China5402022-10-182022-12-08
A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rilpivirine Tablets (RPV)
Azvudine tablets(FNC) and Rilpivirine Tablets (RPV), Azvudine tablets (FNC) and Rilpivirine Tablets (RPV) - Healthy
Phase 1CompletedHenan Genuine Biotech Co., Ltd.152022-02-212025-06-03
Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)
AZVUDINE, AZVUDINE placebo - COVID-19
Phase 3CompletedHRH Pharmaceuticals Limited3122022-01-152022-08-12
Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)
AZVUDINE, AZVUDINE placebo - COVID-19
Phase 3CompletedHRH Pharmaceuticals Limited1802021-04-232022-08-12
Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients
FNC, 3TC, TDF - HIV-infection/Aids
Phase 3UnknownHenan Genuine Biotech Co., Ltd.7202020-04-012020-03-11

Conditions studied

COVID-19 (9)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Hepatitis B, Chronic (1)  ·  Renal Insufficiency (1)

Sponsors

Henan Genuine Biotech Co., Ltd. (4)  ·  Shanghai Henlius Biotech (3)  ·  HRH Pharmaceuticals Limited (2)  ·  Fifth Affiliated Hospital, Sun Yat-Sen University (1)  ·  Peking Union Medical College Hospital (1)  ·  Qianfoshan Hospital (1)  ·  Shandong Provincial Hospital (1)  ·  Southeast University, China (1)  ·  The First Affiliated Hospital of Zhengzhou University (1)  ·  Zhigang Ren (1)

Countries

China (12)  ·  Brazil (2)  ·  Malaysia (1)  ·  Philippines (1)

Top investigators

Gerard S. Garcia, M.D. (1)  ·  Sheila P Figueiredo, MSc (1)  ·  Sheila P Figueiredo, Nurse,MSc (1)  ·  Songqiao Liu, MD. PhD. (1)  ·  Zujiang Yu, Dr. (1)

Results publications

PMID 37007788, PMID 37928473, PMID 38254211, PMID 40389963, PMID 40578868